Infectious Disease Therapeutics Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Infectious Disease Therapeutics Market Valuation Change Between Now And 2029?
In the last few years, the market size for infectious disease therapeutics has seen substantial growth. The market is projected to expand from 2024’s $141.08 billion to $150.6 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The surge in growth during this period is attributed to various factors such as increased instances of infectious diseases, growing occurrence of viral diseases, more awareness about diagnostic procedures, escalating demand for efficient and timely diagnostic testing, burgeoning requirement for cost-effective generic medications, a rising prevalence of infectious diseases, and the escalating significance of antimicrobial stewardship.
In the coming years, the market size of therapeutics for infectious diseases is poised to witness significant growth, escalating to $191.97 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. The progression in the forecast period can be ascribed to factors such as increased investments, augmentation of clinical trial studies, the rising number of clinical trials, heightened attention towards preventing infectious diseases, and growing cognizance for early diagnosis. The forecast period will also see dominant trends such as collaborations, product approvals, investments, and research and development in the therapeutics arena.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp
What Underlying Factors Are Supporting The Infectious Disease Therapeutics Market Growth?
An increase in the occurrence of infectious diseases is projected to boost the infectious disease therapeutics market. Pathogenic organisms like bacteria, fungi, viruses, prions, or parasites are responsible for these diseases. Multiple elements such as ecological disruption, increasing interactions with animals, climate change, antimicrobial resistance, and weakened immune systems contribute to the rise of these diseases. Therapies for these diseases perform a crucial function in managing these infections, lessening morbidity and mortality, and halting the transmission of these diseases amongst communities and across populations. The Centers for Disease Control and Prevention, a government agency from the US, revealed in November 2023 that there were 8,331 tuberculosis (TB) cases in 2022 in the United States, representing an incidence rate of 2.5 per 100,000 people. The number of cases rose by 5.9% and the incident rate saw a 5.5% boost compared to figures from 2021. Consequently, escalating occurrences of infectious diseases steer the growth of the infectious disease therapeutics market.
Which Sub-Segments Are Driving Growth Within The Infectious Disease Therapeutics Market?
The infectious disease therapeuticsmarket covered in this report is segmented –
1) By Type: Drugs; Vaccines
2) By Disease: Tuberculosis; HIV/AIDS; Influenza; Hepatitis; Other Diseases
3) By End-User: Hospitals And Clinics; Retail Pharmacies; Research Organizations; Other End Users
Subsegments:
1) By Drugs – Antibiotics; Antivirals; Antifungals; Antiparasitics; Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines – Inactivated Vaccines; Live Attenuated Vaccines; Subunit Vaccines; Mrna Vaccines; Dna Vaccines; Toxoid Vaccines
What Key Trends Are Driving Growth In The Infectious Disease Therapeutics Market?
Major firms in the infectious disease therapeutics market are putting money into infectious disease drugs with goals to innovate more effective therapies, battle antimicrobial resistance, broaden their product offerings, and respond to emerging infectious hazards. These investments are targeted towards enhancing patient results, fulfilling unfulfilled medical necessities, and aiding international public health initiatives in the control and management of infectious diseases. For example, in June 2022, the UK’s GSK healthcare company committed £1 billion ($1.09 billion) to proactively tackle infectious diseases prevalent in less affluent countries. This move is designed to boost research and development in order to address diseases that have a greater impact on these areas. The significant gap in health research funding and resources between wealthy and low- to middle-income countries highlights the pressing need for such forward-thinking investments to boost population health equally.
Which Companies Hold A Competitive Edge In The 991 Market?
Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.
Access The Complete Report Here:
Which Region Dominates The Infectious Disease Therapeutics Market Today?
North America was the largest region in the infectious disease therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15594&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Therapeutics Market 2025, By The Business Research Company
Veterinary Infectious Disease Diagnostics Global Market Report 2025
Veterinary Anti Infectives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report
Infection Prevention Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
